Comparing New Eye Imaging Technology With Standard Methods
Part of Eyes & vision clinical trials.
This study evaluates a new retinal imaging device (Intalight Dream OCTA) by comparing its images with standard eye imaging methods. If you have a retinal condition that requires imaging tests, this trial helps doctors understand how well the new technology works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 22 years old or older
- Have a retinal condition that needs standard imaging tests (FA or ICGA)
- Have vision of 20/400 or better in at least one eye
- Be able to sit still for eye imaging tests without discomfort
- Have clear enough eye structures to get good quality images
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two non-invasive imaging machines (OCT) that take detailed pictures of eye tumors. The goal is to see which machine gives better images, helping doctors choose the best tool for diagnosing and monitoring eye tumors.
This trial uses a special camera (OCT) to capture detailed images of the eye. It aims to improve eye disease detection. You may join if you have retinal disease, glaucoma, corneal disease, or healthy eyes.
This study tests a new eye imaging device to see if it can take clear pictures of the back of the eye. It may help doctors better see and monitor conditions like macular degeneration and diabetic retinopathy.
This study tests a new eye scanner that takes detailed pictures of the back of the eye. It may help doctors see eye problems more clearly and could lead to better care.
This study tests an investigational device that looks at the blood vessels in your eye and how blood flows through them. It compares those images with pictures taken during your regular eye exam to see if the device can help doctors better understand eye health.
This trial compares two different imaging systems (Clarus and Optos) to see how well they can capture images of the retina in people with inherited retinal diseases. The goal is to find which system works better for diagnosing and tracking these conditions.
Hear when a new Retina Pathology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.